These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9883678)

  • 21. Shed gangliosides provide detergent-independent evidence for type-3 glycosynapses.
    Thorne RF; Mhaidat NM; Ralston KJ; Burns GF
    Biochem Biophys Res Commun; 2007 Apr; 356(1):306-11. PubMed ID: 17350595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of glucosylceramide synthase.
    Shayman JA; Lee L; Abe A; Shu L
    Methods Enzymol; 2000; 311():373-87. PubMed ID: 10563341
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for a role of glycosphingolipids in CXCR4-dependent cell migration.
    Limatola C; Massa V; Lauro C; Catalano M; Giovanetti A; Nuccitelli S; Spinedi A
    FEBS Lett; 2007 Jun; 581(14):2641-6. PubMed ID: 17511990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances.
    Radin NS; Shayman JA; Inokuchi J
    Adv Lipid Res; 1993; 26():183-213. PubMed ID: 8379450
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.
    di Bartolomeo S; Spinedi A
    Biochem Biophys Res Commun; 2001 Oct; 288(1):269-74. PubMed ID: 11594784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP).
    Inokuchi J; Mizutani A; Jimbo M; Usuki S; Yamagishi K; Mochizuki H; Muramoto K; Kobayashi K; Kuroda Y; Iwasaki K; Ohgami Y; Fujiwara M
    Biochem Biophys Res Commun; 1997 Aug; 237(3):595-600. PubMed ID: 9299410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agents for the treatment of glycosphingolipid storage disorders.
    Abe A; Wild SR; Lee WL; Shayman JA
    Curr Drug Metab; 2001 Sep; 2(3):331-8. PubMed ID: 11513334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning and functional characterization of two key enzymes of glycosphingolipid biosynthesis in the amphibian Xenopus laevis.
    Luque ME; Crespo PM; Mónaco ME; Aybar MJ; Daniotti JL; Sánchez SS
    Dev Dyn; 2008 Jan; 237(1):112-23. PubMed ID: 18095347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.
    Makino A; Ishii K; Murate M; Hayakawa T; Suzuki Y; Suzuki M; Ito K; Fujisawa T; Matsuo H; Ishitsuka R; Kobayashi T
    Biochemistry; 2006 Apr; 45(14):4530-41. PubMed ID: 16584188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gangliosides in the nervous system].
    Tsuji S; Nagai Y
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(4 Suppl):535-45. PubMed ID: 2159169
    [No Abstract]   [Full Text] [Related]  

  • 31. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase.
    Nicholson KM; Quinn DM; Kellett GL; Warr JR
    Br J Cancer; 1999 Oct; 81(3):423-30. PubMed ID: 10507766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders.
    Fredman P; Lekman A
    Neurochem Res; 1997 Aug; 22(8):1071-83. PubMed ID: 9239764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous determination of sugar incorporation into glycosphingolipids and glycoproteins.
    Paul P; Bordmann A; Rosenfelder G; Towbin H
    Anal Biochem; 1992 Aug; 204(2):265-72. PubMed ID: 1443524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin.
    Platt FM; Reinkensmeier G; Dwek RA; Butters TD
    J Biol Chem; 1997 Aug; 272(31):19365-72. PubMed ID: 9235935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of glycosphingolipid biosynthesis induces cytokinesis failure.
    Atilla-Gokcumen GE; Bedigian AV; Sasse S; Eggert US
    J Am Chem Soc; 2011 Jul; 133(26):10010-3. PubMed ID: 21668028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of the Coomassie brilliant blue staining method for sphingolipids and sphingolipid synthesis inhibitors on silica gel thin-layer plate.
    Abe A
    Anal Biochem; 1998 Apr; 258(1):149-50. PubMed ID: 9527864
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo influence of ceramide accumulation induced by treatment with a glucosylceramide synthase inhibitor on ischemic neuronal cell death.
    Hisaki H; Shimasaki H; Ueta N; Kubota M; Nakane M; Nakagomi T; Tamura A; Masuda H
    Brain Res; 2004 Aug; 1018(1):73-7. PubMed ID: 15262207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced inflammatory potential of peritoneal macrophages recruited in mice pretreated with a glycolipid synthesis inhibitor.
    Yohe HC; Kitzmiller TJ; Bement WJ; Dwyer BE; Sinclair JF
    Inflammopharmacology; 2006 Aug; 14(3-4):170-5. PubMed ID: 16983496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New PDMP analogues inhibit process outgrowth in an insect cell line.
    Slavish JP; Friel DK; Oland LA; Polt R
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1487-90. PubMed ID: 15006387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosphingolipid biosynthesis may not be necessary for vertebrate brain development.
    Brigande JV; Seyfried TN
    Ann N Y Acad Sci; 1998 Jun; 845():215-8. PubMed ID: 9668354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.